KRTX Karuna Therapeutics Inc: Accounting Value per Share

Graphic logo of Karuna Therapeutics (KRTX)

Support from a global healthcare behemoth has provided Karuna Therapeutics (KRTX) with financial stability and coverage of development costs. Data on the book value per share confirm this trend, where 32.96 serves as the base value of the parameter. Capitalization growth is based on R&D alliances for schizophrenia treatment, which led to an M&A deal. High margins for serial production are guaranteed by the ownership of unique patents in psychiatry.

Karuna Therapeutics Inc (KRTX): Share Book Value from 07/04/2022 to 03/23/2024

karunatx.com - analytical breakdowns and key metrics (KRTX)

- price and consensus price forecast:
Stock Quotes Karuna|KRTX - Analyst Forecast Prices
- market capitalization data:
Market Valuation Karuna Therapeutics, Inc.|KRTX - Business Value
- book capitalization data:
Net Assets per Single Share Karuna Therapeutics|KRTX - Net Asset Value|Market Capitalization to Book Value Ratio karunatx.com|KRTX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Karuna Therapeutics|KRTX - Long-Term Debt to Capital|Short-Term Debt to Equity Karuna Therapeutics, Inc.|KRTX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Karuna Therapeutics, Inc.|KRTX - Company Long-Term Liabilities|Company Short-Term Debts Karuna Therapeutics
Fundamental company valuation:Karuna - KRTX
Manufactured products of Karuna Therapeutics, Inc.

Book value per share reflects the portion of equity attributable to a single security and serves as an indicator of the business's intrinsic value net of all liabilities. By analyzing the current book value per share, an investor can see how the commercialization of KarXT converts scientific research into tangible net assets, strengthening the financial stability of Karuna Therapeutics (KRTX).

Competitors of Karuna Therapeutics (KRTX)

Accounting Value per Share Alkermes Inc. ALKS|Avadel Corp (AVDL) - Book Price of a Share|Accounting Value per Share Atai Life Sciences N.V.|GHRS (ghres.com) - Equity per Share|Net Assets per Single Share MindMed MNMD|Share Book Value COMPASS Pathways PLC|LB Pharma (LBRX) - Book Value per Share|Accounting Value of a Share Bright Minds Corp (DRUG)|Book Value per Share VNDA (Vanda Pharmaceuticals)|Cybin Inc - Book Value per Share|Net Assets per Single Share Alto Neuroscience (ANRO)|NRXP: Accounting Value of a Share|CING (cingulate.com) - Net Assets per Single Share|silopharma.com (SILO) - Accounting Value per Share|CPHI (China Pharma Holdings Inc.) - Book Value per Share|Book Value per Share Clearmind Medicine, Inc. (CMND)|Psyence Biomedical (PBM) - Accounting Value per Share|Accounting Value of a Share SPRC (SciSparc Ltd.)|Seelos Therapeutics, Inc (SEEL) - Net Assets per Single Share|Virpax Pharmaceuticals Inc. - Share Book Value